Norway's OTC Market In 2018: Sales Remain Stable As GSK Consolidates Its Leading Position
Executive Summary
Sales of non-prescription medicines in Norway edged up by less than 1% in 2018, as GSK remained the leading player on the market and its Otrivin respiratory line maintained its position as the country's best-selling OTC brand.
You may also be interested in...
Karo Grabs Sweden’s Trimb To Grow Presence In Nordics
Karo’s new private-equity owners have flexed their muscles to snap up Sweden’s Trimb in a move which will expand the company’s reach in the Nordics and beyond.
People Round-Up: Appointments At Afipa, J&J, Stada, WSMI, And Karo
J&J Consumer has a new chairman, Stada UK gets a permanent head, and Karo names its next CEO. On the association front, France's Afipa and the WSMI elect new leaders.
Nestlé Spies APAC Expansion Potential With Deal for New Zealand's Better Health
Nestlé Health Science continues to expand its dietary supplements offering in 2022 penning a deal for New Zealand's The Better Health Company and its GO Healthy brand. The company says the deal will strengthen its presence not just in New Zealand but across the wider APAC region in markets such as Australia and China.